Evidence map›Paper›PMID 24813081›Full record

ArticleBlood cancer journal2014

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma.

P Campbell, P Walker, S Avery, S Patil, D Curtis, A Schwarer, A Wei, A Kalff, J Muirhead, A Spencer

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

P Campbell1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Department of Clinical Haematology, Andrew Love Cancer Centre, Barwon Health - The Geelong Hospital, Geelong, Victoria, Australia [3] Deakin University School of Medicine, Waurn Ponds, Victoria, Australia.
P Walker1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
S Avery1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
S Patil1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
D Curtis1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
A Schwarer1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
A Wei1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
A Kalff1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
J MuirheadMalignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia.
A Spencer1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedCohort StudiesDisease-Free SurvivalFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedMultiple MyelomaOutpatientsSurvival RateTransplantation Conditioning

Identifiers

PMID24813081
PMCPMC4042303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.